Intravenous Albumin for Mitigating Hypotension and Augmenting Ultrafiltration during Kidney Replacement Therapy

医学 低蛋白血症 肿大压 血管内容积状态 重症监护医学 血液透析 白蛋白 败血症 低血容量 休克(循环) 血清白蛋白 超滤(肾) 麻醉 外科 内科学 血流动力学 化学 色谱法
作者
Nicole Hryciw,Michael Joannidis,Swapnil Hiremath,Jeannie Callum,Edward G. Clark
出处
期刊:Clinical Journal of The American Society of Nephrology [Lippincott Williams & Wilkins]
卷期号:16 (5): 820-828 被引量:41
标识
DOI:10.2215/cjn.09670620
摘要

Among its many functions, owing to its oversized effect on colloid oncotic pressure, intravascular albumin helps preserve the effective circulatory volume. Hypoalbuminemia is common in hospitalized patients and is found especially frequently in patients who require KRT either for AKI or as maintenance hemodialysis. In such patients, hypoalbuminemia is strongly associated with morbidity, intradialytic hypotension, and mortality. Intravenous albumin may be administered in an effort to prevent or treat hypotension or to augment fluid removal, but this practice is controversial. Theoretically, intravenous albumin administration might prevent or treat hypotension by promoting plasma refilling in response to ultrafiltration. However, clinical trials have demonstrated that albumin administration is not nearly as effective a volume expander as might be assumed according to its oncotic properties. Although intravenous albumin is generally considered to be safe, it is also very expensive. In addition, there are potential risks to using it to prevent or treat intradialytic hypotension. Some recent studies have suggested that hyperoncotic albumin solutions may precipitate or worsen AKI in patients with sepsis or shock; however, the overall evidence supporting this effect is weak. In this review, we explore the theoretical benefits and risks of using intravenous albumin to mitigate intradialytic hypotension and/or enhance ultrafiltration and summarize the current evidence relating to this practice. This includes studies relevant to its use in patients on maintenance hemodialysis and critically ill patients with AKI who require KRT in the intensive care unit. Despite evidence of its frequent use and high costs, at present, there are minimal data that support the routine use of intravenous albumin during KRT. As such, adequately powered trials to evaluate the efficacy of intravenous albumin in this setting are clearly needed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
江枫渔火完成签到 ,获得积分10
刚刚
香蕉面包完成签到 ,获得积分10
1秒前
聪慧芷巧完成签到,获得积分10
7秒前
Patience完成签到,获得积分10
7秒前
积极钧完成签到,获得积分10
8秒前
朱科源啊源完成签到 ,获得积分10
10秒前
ZQ完成签到 ,获得积分10
10秒前
是阿龙呀完成签到 ,获得积分10
11秒前
breathless应助阔达的哲瀚采纳,获得30
11秒前
雪山飞龙完成签到,获得积分10
12秒前
12秒前
明镜完成签到,获得积分10
13秒前
zxd完成签到,获得积分10
13秒前
15秒前
bi完成签到 ,获得积分10
18秒前
谦让丹翠完成签到,获得积分10
19秒前
www完成签到 ,获得积分10
19秒前
胖胖橘完成签到 ,获得积分10
20秒前
gg发布了新的文献求助10
20秒前
昴星引路完成签到 ,获得积分10
21秒前
gaowei完成签到 ,获得积分10
23秒前
古柳完成签到,获得积分10
25秒前
大力的安阳完成签到 ,获得积分10
27秒前
alixy完成签到,获得积分10
31秒前
木木杨完成签到,获得积分10
31秒前
袅晴丝完成签到 ,获得积分10
32秒前
33秒前
南风完成签到,获得积分10
33秒前
今后应助Bob采纳,获得10
34秒前
阿华发布了新的文献求助10
37秒前
genova完成签到,获得积分10
37秒前
敏感的灵凡完成签到 ,获得积分10
37秒前
39秒前
39秒前
爱啥啥发布了新的文献求助10
40秒前
一玮完成签到 ,获得积分10
43秒前
44秒前
yellow完成签到,获得积分10
45秒前
jake完成签到,获得积分10
45秒前
48秒前
高分求助中
Annie Ernaux: De la perte au corps glorieux 600
Petrology and Plate Tectonics,2025 500
Optical Coating Design with the Essential Macleod 400
A revision of Limenitis helmanni and its related species (Nymphalidae) from Central and South China 400
Moore's Clinically Oriented Anatomy 10th Edition 400
Direct and Iterative Linear System Solvers 400
Cardiopulmonary Bypass and Mechanical Support: Principles and Practice, Fifth Edition 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6782032
求助须知:如何正确求助?哪些是违规求助? 8504489
关于积分的说明 18112283
捐赠科研通 6084941
什么是DOI,文献DOI怎么找? 3018784
邀请新用户注册赠送积分活动 1995672
关于科研通互助平台的介绍 1980406